Latest Insider Transactions at West Pharmaceutical Services Inc (WST)
This section provides a real-time view of insider transactions for West Pharmaceutical Services Inc (WST). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of WEST PHARMACEUTICAL SERVICES INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of WEST PHARMACEUTICAL SERVICES INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 29
2024
|
Charles Witherspoon VP & Treasurer |
SELL
Open market or private sale
|
Direct |
703
-19.83%
|
$217,930
$310.4 P/Share
|
|
Oct 29
2024
|
Charles Witherspoon VP & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
478
+19.64%
|
$82,694
$173.22 P/Share
|
|
Oct 29
2024
|
Silji Abraham SVP, Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
180
-5.43%
|
$57,240
$318.41 P/Share
|
|
Oct 29
2024
|
Silji Abraham SVP, Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
458
+12.13%
|
-
|
|
Aug 19
2024
|
Charles Witherspoon VP & Treasurer |
SELL
Open market or private sale
|
Direct |
1,029
-23.19%
|
$308,700
$300.0 P/Share
|
|
Aug 19
2024
|
Charles Witherspoon VP & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
529
+17.42%
|
$53,958
$102.51 P/Share
|
|
Aug 06
2024
|
Eric Mark Green President, CEO and Board Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
36,732
+8.6%
|
$2,167,188
$59.64 P/Share
|
|
Aug 06
2024
|
Eric Mark Green President, CEO and Board Chair |
SELL
Open market or private sale
|
Direct |
30,732
-15.95%
|
$9,342,528
$304.71 P/Share
|
|
Jun 12
2024
|
Silji Abraham SVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
1,800
-38.63%
|
$594,000
$330.78 P/Share
|
|
May 10
2024
|
Thomas W Hofmann Director |
SELL
Open market or private sale
|
Direct |
617
-1.4%
|
$225,205
$365.92 P/Share
|
|
May 07
2024
|
Eric Mark Green President, CEO and Board Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
75,000
+8.64%
|
$4,350,000
$58.51 P/Share
|
|
May 07
2024
|
Eric Mark Green President, CEO and Board Chair |
SELL
Open market or private sale
|
Direct |
66,000
-10.96%
|
$24,156,000
$366.65 P/Share
|
|
Apr 23
2024
|
Paolo Pucci Director |
BUY
Grant, award, or other acquisition
|
Direct |
564
+5.4%
|
-
|
|
Apr 23
2024
|
Goldman Myla Lai Director |
BUY
Grant, award, or other acquisition
|
Direct |
564
+2.98%
|
-
|
|
Apr 23
2024
|
Douglas A Michels Director |
BUY
Grant, award, or other acquisition
|
Direct |
564
+1.26%
|
-
|
|
Apr 23
2024
|
Stephen H Lockhart Director |
BUY
Grant, award, or other acquisition
|
Direct |
564
+25.66%
|
-
|
|
Apr 23
2024
|
Deborah L Keller Director |
BUY
Grant, award, or other acquisition
|
Direct |
564
+5.56%
|
-
|
|
Apr 23
2024
|
Robert F Friel Director |
BUY
Grant, award, or other acquisition
|
Direct |
564
+13.51%
|
-
|
|
Apr 23
2024
|
Molly Joseph Director |
BUY
Grant, award, or other acquisition
|
Direct |
564
+23.74%
|
-
|
|
Apr 23
2024
|
Mark A Buthman Director |
BUY
Grant, award, or other acquisition
|
Direct |
564
+1.33%
|
-
|
|
Apr 23
2024
|
William F Feehery Director |
BUY
Grant, award, or other acquisition
|
Direct |
564
+1.83%
|
-
|
|
Apr 23
2024
|
Thomas W Hofmann Director |
BUY
Grant, award, or other acquisition
|
Direct |
564
+1.26%
|
-
|
|
Mar 11
2024
|
Chad Winters VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
815
-38.39%
|
$291,770
$358.82 P/Share
|
|
Mar 11
2024
|
Chad Winters VP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
675
+24.12%
|
$116,775
$173.22 P/Share
|
|
Feb 28
2024
|
Charles Witherspoon VP & Treasurer |
SELL
Open market or private sale
|
Direct |
2,019
-50.5%
|
$722,802
$358.62 P/Share
|
|
Feb 28
2024
|
Charles Witherspoon VP & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,019
+33.55%
|
$205,938
$102.51 P/Share
|
|
Feb 27
2024
|
Eric Mark Green President, CEO and Board Chair |
BUY
Exercise of conversion of derivative security
|
Direct |
73,132
+14.18%
|
$4,168,524
$57.38 P/Share
|
|
Feb 27
2024
|
Eric Mark Green President, CEO and Board Chair |
SELL
Open market or private sale
|
Direct |
64,132
-29.55%
|
$23,023,388
$359.85 P/Share
|
|
Feb 23
2024
|
Silji Abraham SVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
7,012
-60.08%
|
$2,559,380
$365.0 P/Share
|
|
Feb 23
2024
|
Silji Abraham SVP, Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,012
+37.53%
|
$1,213,076
$173.22 P/Share
|
|
Feb 20
2024
|
Charles Witherspoon VP & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
144
+6.78%
|
-
|
|
Feb 20
2024
|
Chad Winters VP, Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
179
+11.0%
|
-
|
|
Feb 20
2024
|
Cindy Reiss Clark Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
551
+10.14%
|
-
|
|
Feb 20
2024
|
Kimberly Banks Mac Kay SVP, GC & Corporate Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
720
+34.65%
|
-
|
|
Feb 20
2024
|
Annette F Favorite Sr. VP & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
541
+7.68%
|
-
|
|
Feb 20
2024
|
Quintin J Lai VP Strat & Investor Relations |
BUY
Grant, award, or other acquisition
|
Direct |
375
+7.92%
|
-
|
|
Feb 20
2024
|
Silji Abraham SVP, Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
646
+12.17%
|
-
|
|
Feb 20
2024
|
Bernard Birkett Sr VP, Chief Fin & Ops Off |
BUY
Grant, award, or other acquisition
|
Direct |
1,969
+22.23%
|
-
|
|
Feb 20
2024
|
Eric Mark Green President, CEO and Board Chair |
BUY
Grant, award, or other acquisition
|
Direct |
6,567
+4.24%
|
-
|
|
Dec 11
2023
|
Annette F Favorite Sr. VP & Chief HR Officer |
SELL
Bona fide gift
|
Direct |
584
-8.92%
|
-
|
|
Dec 06
2023
|
Eric Mark Green President, CEO and Board Chair |
SELL
Bona fide gift
|
Direct |
9,800
-6.97%
|
$3,361,400
$343.0 P/Share
|
|
Dec 01
2023
|
Chad Winters VP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
797
+16.01%
|
$125,926
$158.32 P/Share
|
|
Dec 01
2023
|
Chad Winters VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,013
-44.39%
|
$353,537
$349.0 P/Share
|
|
Oct 31
2023
|
Charles Witherspoon VP & Treasurer |
SELL
Open market or private sale
|
Direct |
1,190
-22.08%
|
$383,180
$322.38 P/Share
|
|
Oct 31
2023
|
Charles Witherspoon VP & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,190
+18.05%
|
$265,370
$223.76 P/Share
|
|
Aug 30
2023
|
Annette F Favorite Sr. VP & Chief HR Officer |
SELL
Open market or private sale
|
Direct |
2,000
-6.1%
|
$828,000
$414.55 P/Share
|
|
Aug 30
2023
|
Annette F Favorite Sr. VP & Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+10.6%
|
$166,000
$83.47 P/Share
|
|
Aug 22
2023
|
Cindy Reiss Clark Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,477
-44.59%
|
$1,366,461
$393.34 P/Share
|
|
Aug 22
2023
|
Cindy Reiss Clark Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,477
+14.83%
|
$945,744
$272.21 P/Share
|
|
Aug 11
2023
|
Quintin J Lai VP Strat & Investor Relations |
SELL
Open market or private sale
|
Direct |
21,101
-22.0%
|
$8,334,895
$395.43 P/Share
|